Human proinsulin normalizes fasting hyperglycemia in patients with NIDDM.
Pasmantier
R M
RM
Department of Medicine, State University of New York Health Science Center, Brooklyn.
Hirsch
S R
SR
Lebovitz
H E
HE
D001786:Blood Glucose / Q000032:analysis; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011384:Proinsulin / Q000627:therapeutic use*
D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D011384:Proinsulin